Loading clinical trials...

Clinical Data-Driven AI Model for Mortality Prediction After Hip Fracture | Clinical Trials | Clareo Health

COMPLETEDNCT07495527

Clinical Data-Driven AI Model for Mortality Prediction After Hip Fracture

Hip fractures are a major cause of morbidity and mortality, particularly in elderly patients. Accurate prediction of postoperative mortality is critical for risk stratification and clinical decision-m...

Lead sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment1,000

Start dateDec 2025

Last updatedMar 27, 2026

Condition

Hip Fracture , Postoperative Mortality

Locations shown

Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Ankara

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 27, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions